By Leonid Schneider, on research integrity, biomedical ethics and academic publishing
Professor Ruben Plentz chose to focus his career on clinical medicine in Bremen, despite his tremendous academic achievements in cancer research. Was it because malicious critics harassed him with frivolous investigations and corrections, envious at all those peer-reviewed cancer cures the great doctor invented?
On 27 December 2018, I received an email from the Italian Office for Protection of Personal Data. A certain Professor Giorgio Zauli has reported me for publishing an official letter his University of Ferrara sent to me on his behalf.
Eric Lam is yet another of the many “Curing Cancer with Photoshop” researchers which PubPeer is full of. This professor of molecular Oncology at Imperial College in London is responsible for several papers with duplicated gel bands, but does it matter? He has 250 more.
Two and a half years after Maria Fousteri was found guilty of scientific misconduct by her former employer, the Leiden University Medical Center (LUMC), exactly nothing at all happened. ERC and Molecular Cell ignored LUMC letters from June 2016, while Fouster’s British co-authors interfered to save own papers. Of 4 scheduled retractions, none took place.
Following my reporting, the cancer researcher Carlos López-Otín abandoned his ERC-funded 36-member-strong “Degradome” lab at the University of Oviedo in Spain and moved in with his collaborator in Paris, France, Guido Kroemer. Yet Lopez-Otin’s data integrity issues seem as poppycock compared to what Kroemer and his life partner Laurence Zitvogel dished out to the scientific community.
The World Health Organisation (WHO) has a cancer research unit in France, IARC. Some papers from there contain impressive manipulations. The works of art are authored by Massimo Tommasino and his former junior colleague there Uzma Hasan, now tenured group leader at INSERM. Some of this research took place at the Schering-Plough Research Institute which was taken over by German pharma giant Merck.
The fraud case of Bristol cell biologist Abderrahmane Kaidi looked rather straightforward: Bristol University caught a group leader on data faking and bullying, and immediately had him removed. Turns out, it was not really like that.
Now I publish some very revealing leaked material, spiced with stories of a guerrilla Twitter account and a deleted student newspaper article.
University of Bristol mysteriously lost its senior lecturer, Abderrahmane Kaidi. His institutional website was wiped out in August 2018. I obtained an internal email which lifts the mystery: Kaidi was namely found guilty of “having fabricated research data”, and resigned with “immediate effect”. Affected by research misconduct are also publications from Kaidi’s postdoc period with Stephen Jackson in Cambridge.
With nobody above him, ICR director Paul Workman was seemingly investigating himself, and found two female colleagues guilty of placing fake data into his papers, primarily the ICR emeritus Ann Jackman. One paper was retracted, another received an outrageous correction. The previous ICR CEO, Alan Ashworth, together with his right-hand man Chris Lord, have their own impressive, but hitherto ignored, record on PubPeer.
Louis J. Ignarro knew how to monetize his 1998 Nobel Prize for discovery of nitric oxide as molecular cell signalling agent. He made many millions selling dietary supplement for Herbalife and pomegranate juice for POM Wonderful Company. Some of that found its way (without proper conflict of interest declaration) into Ignarro’s peer reviewed papers. Those, done in collaboration with certain Photoshop artists like Claudio Napoli, contain clearly fabricated data.
For Better Science